{"id":"W4282970409","doi":"10.2217/fon-2022-0380","title":"A phase II clinical trial of neoadjuvant sasanlimab and stereotactic body radiation therapy as an <i>in situ</i> vaccine for cisplatin-ineligible MIBC: the RAD VACCINE MIBC trial","year":2022,"lang":"en","type":"article","venue":"Future Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"National Cancer Institute; Pfizer","keywords":"Medicine; Oncology; Cystectomy; Bladder cancer; Internal medicine; Radiation therapy; Clinical trial; Cisplatin; Neoadjuvant therapy; Immune checkpoint; Chemotherapy; Cancer; Immunotherapy; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001350141,0.001189018,0.001349794,0.000261144,0.0003882715,0.0009178056,0.0005825773,0.001425492,0.003435163],"category_scores_gemma":[0.0008528003,0.0004075184,0.0008374869,0.0002120436,0.0008322095,0.000781782,0.0002736149,0.003068431,0.0006892952],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007915787,"about_ca_system_score_gemma":0.001842286,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006174972,"about_ca_topic_score_gemma":0.001895742,"domain_scores_codex":[0.9995967,0.0002100002,0.00001708321,0.00006806482,0.00003448562,0.00007387416],"domain_scores_gemma":[0.9994107,0.00008797052,0.00009109244,0.00004951916,0.0000379699,0.0003226293],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7897347,0.07780874,0.003190563,0.0006668888,0.00102834,0.0001638399,0.0002185181,0.002529428,0.03745751,0.0008707629,0.00763773,0.07869301],"study_design_scores_gemma":[0.5870121,0.3963792,0.004226329,0.0000395455,0.0003182057,0.0001598494,0.00005486769,0.001675675,0.004228591,0.0004616696,0.005413362,0.0000306262],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9847073,0.001888093,0.0009177669,0.001568401,0.0004768124,0.004126645,0.001154605,0.000118893,0.005041496],"genre_scores_gemma":[0.9782394,0.001514107,0.002983751,0.002187304,0.0003462719,0.005444799,0.002503527,0.0000306338,0.006750233],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003435163,"threshold_uncertainty_score":0.01149178,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04402021379365379,"score_gpt":0.4166381891270673,"score_spread":0.3726179753334135,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}